# Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection

> **NCT04359862** · PHASE4 · TERMINATED · sponsor: **Fundación para la Investigación del Hospital Clínico de Valencia** · enrollment: 19 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome
- COVID19 Infection

## Interventions

- **DRUG:** Sevoflurane
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT04359862
- **Lead sponsor:** Fundación para la Investigación del Hospital Clínico de Valencia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-16
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-03-31
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Low recruitment ratio
- **Last updated:** 2021-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04359862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04359862, "Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04359862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*